SDSU / UCSD · Joint Doctoral Program

Hamza Hajama

Translational microbiology · Phage therapy · genomics & microbiome

I investigate how phages (viruses that infect bacteria) can help address antibiotic-resistant infections, how bacteria and microbial communities change during treatment. My research covers therapeutic phage isolation and characterization, bacterial genetics, metagenomics and microbial ecology.

Doctoral researcher in Cell and Molecular Biology, currently exploring postdoctoral opportunities.

Clinical/translational
≈8 cases, so far Research contributions under IND/eIND authorizations
Published manuscripts
>4 peer reviewed One pre-print
Professional outreach
>10 conferences National and international

Selected study · Co-first author · 2023

Tracking the progress of a phage-therapy case through sputum and blood metagenomics.

Our 2023 case report assessed the progress of phage therapy for a MDR Achromobacter infection in an 11-year-old patient with cystic fibrosis. I isolated, characterized, and prepared the phages as well as tracking the progress of the treatment course using metagenomics on longitudinal blood and sputum samples.

Rather than targeting the 16S marker gene, we used WGS shotgun sequencing to obtain all DNA across in the sample, including bacterial, fungal, and viral DNA. This makes it possible to investigate the target pathogen and therapeutic phages within a broader microbial context, in addition to microbiome shifts.

the case report
Clinical setting
Pediatric cystic fibrosis
Target organism
Multidrug-resistant Achromobacter
Sampling types
Longitudinal
Approach
WGS shotgun sequencing, metagenomics, ecology
Publication
Pediatric Infectious Disease Journal
42(9):754–759 · 2023

A clinical case report describing one treatment course; the same patient received two more rounds of phages, manuscript for the subsequent rounds is in prep.

Research

What changes during phage therapy—and why?

Phages infect bacteria, making them ideal candidates for treating MDR infections. But finding a good phage is only the beginning: its bacterial host can and will develop resistance and the CF lung boasts a complex microbial community. My project in the Segall Lab focuses on understanding these dynamics, with a focus on Achromobacter infections in cystic fibrosis.

Preparing phages for clinical use

I have contributed to approximately eight phage-therapy cases under investigational new drug (IND) or emergency IND authorizations. My work includes isolating, characterizing, and testing phages and phage–antibiotic synergy and antagonism, preparing phage cocktails and quantifying endotoxin contamination in magistral preps, evaluating phage stability and losses to storage, syringes, tubing, and vials.

Which host factors enable infection?

I combine isolate genomics, phage-susceptibility assays, SNP analyses and genetic complementations to investigate bacterial factors involved in phage infection. My dissertation aims to connect resistance mutations with changes in antibiotic susceptibility and bacterial fitness.

What happens beyond the target pathogen?

I analyze shotgun metagenomes from sputum and blood collected before, during, and after therapy. My ecological research asks how community composition changes and whether groups of bacteria with similar metabolic roles respond together. My dissertation aims to model those patterns.

Methods

Laboratory and computational expertise.

Phage characterization
Phage isolation, purification, Host-range screening, efficiency of plating, growth assays, sequencing, and phage–antibiotic synergy
Translational work
Therapeutic injection-grade lysate preparation, endotoxin removal and quantification, sterility and stability and delivery-material testing
Bacterial genetics
Characterization and complementation of phage-resistant mutants, genotype–phenotype analysis, phylogenomics
Next generation sequencing
DNA extraction,library preparation, short (Illumina) and long (Oxford Nanopore) reads sequencing, data analysis
Genomics
Assembly, annotation, prophage and mobile-genetic elements screening, virulence factors, phylogeny
Metagenomics
WGS metagenomic binning, read mapping, pathogen and therapeutic-phage tracking, community profiling, and SNP/SNV analyses

Publications

Recent papers & preprints.

Google Scholar profile

Teaching

Cell and molecular biology at the bench.

I have taught advanced cell and molecular biology laboratories at SDSU, supported experimental troubleshooting, and provided small-group tutoring. I have presented my phage-therapy research at Viruses of Microbes, the Cystic Fibrosis Workshop, UC Irvine, and other research meetings.

Talks, teaching, and awards in my CV

About

Doctoral training at SDSU and UC San Diego.

I am a doctoral researcher in the SDSU–UC San Diego Joint Doctoral Program in Cell and Molecular Biology, working with Anca M. Segall. I earned my B.S. in Biology at SDSU in 2020, following degrees in biology and chemistry at Santa Barbara City College. For my postdoctoral work, I am interested in linking mechanisms of phage infection with bacterial evolution and microbial-community responses.

Let's get in touch!

Open to postdoctoral opportunities & research collaborations.

hhm@sdsu.edu